Articles

January 3, 2023
Articles

Trends Paving The Way For An Influx Of Biosimilar Development

Promising broader patient access to critical medicines, biosimilars offer a more cost-effective alternative therapeutic option compared with originator products. With many patents for blockbuster” commercial biologics set to expire in the next few years, biopharma developers have become increasingly drawn to the biosimilars market.

Click for full article

Featured Expert

Daniel Worms, Ph.D. Associate Principal Investigator — Daniel Worms,
Ph.D. Associate Principal Investigator

Todd Lester Associate Director — Todd Lester
Associate Director

Nathan Rudemiller Ph.D. Associate Director — Nathan Rudemiller
Ph.D. Associate Director

Jennifer Zemo Ph.D. Director — Jennifer Zemo
Ph.D. Director

Jessica Weaver Manager II & Bioanalytical Project Manager — Jessica Weaver
Manager II & Bioanalytical Project Manager

Krystal Alligood Associate Director — Krystal Alligood
Associate Director

Laura Lassen Director — Laura Lassen
Director

Luke Armstrong Ph.D. Manager II — Luke Armstrong
Ph.D. Manager II

Michelle Miller Ph.D. DABT Associate Director — Michelle Miller
Ph.D. DABT Associate Director

Jennifer Johnson Manager I — Jennifer Johnson
Manager I

Jennifer T. Durham Ph.D. Associate Director of Scientific Services, BioAgilytix — Jennifer T. Durham
Ph.D. Associate Director of Scientific Services, BioAgilytix

Jeff Patrick Ph.D. Director of GMP Operations, BioAgilytix — Jeff Patrick
Ph.D. Director of GMP Operations, BioAgilytix

Janina Hajek Ph.D. Principal Investigator — Janina Hajek
Ph.D. Principal Investigator

Janett Schwarz Ph.D. Principal Investigator — Janett Schwarz
Ph.D. Principal Investigator

Imke Müller Ph.D. Director, Principal Investigator — Imke Müller
Ph.D. Director, Principal Investigator

Carla Gibbons Senior QA Director — Carla Gibbons
Senior QA Director

Carla Mejia Manager II — Carla Mejia
Manager II

Daniel Worms Ph.D. Associate Principal Investigator — Daniel Worms
Ph.D. Associate Principal Investigator

David Rusnak Director Bioanalytical Operations — David Rusnak Director
Bioanalytical Operations

Florian Anlauff Ph.D. Principal Investigator — Florian Anlauff
Ph.D. Principal Investigator

Frank Wischnewski Ph.D. Associate Director — Frank Wischnewski
Ph.D. Associate Director

Anita Simkins Senior Vice President, Global Quality Assurance — Anita Simkins
Senior Vice President, Global Quality Assurance

Anne Timmerman Ph.D. Associate Principal Investigator — Anne Timmerman
Ph.D. Associate Principal Investigator

Previous

Next

Ask a Question

Schedule a Conversation

Meet All of Our Experts

Pharmacokinetics & Pharmacodynamics

See how our PK expertise complements our immunogenicity services by evaluating absorption, distribution, metabolism and excretion characteristics of a product.